Suppr超能文献

社区老年肾功能不全患者不适当药物使用与死亡率——基于三城市的人群研究。

Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study.

机构信息

Inserm, Centre for research in Epidemiology and Population Health, U1018, Villejuif, France.

出版信息

Nephrol Dial Transplant. 2011 Sep;26(9):2852-9. doi: 10.1093/ndt/gfq827. Epub 2011 Feb 3.

Abstract

BACKGROUND

Glomerular filtration rate (GFR) decline with age increases the risk of inappropriate dosing of drugs. We investigated the determinants and the mortality associated with the use of drugs that are contraindicated or require dose adjustment according to kidney function among the community-dwelling elderly.

METHODS

The Three-City population-based study included 8701 participants ≥65 years from 1999 to 2001. Exposure to the risk of inappropriate drug dosage was defined as reported use of either a contraindicated drug or one requiring dose adjustment according to the individual baseline glomerular filtration rate estimated (eGFR) with the Modification of Diet in Renal disease study equation. Six-year mortality was analysed using Cox models adjusted for several sociodemographic, biologic and clinical risk factors.

RESULTS

The overall percentage of exposure to the risk of inappropriate drug use was 13.3% (contraindication, 0.8%): it was 52.5% (4.5%) in those with an eGFR of 30-59 and 96% (48%) in those <30 mL/min/1.73 m(2). Antihypertensive agents, fibrates and psycholeptics accounted for most of the drugs with dosing recommendations and antidiabetic agents and antihistamines for those contraindicated. Individuals at risk were more likely to be men, older, and under treatment for hypertension or hypercholesterolemia. Exposure to either risk was independently related to higher all-cause mortality (hazard ratio 1.4, 95% confidence interval 1.0-1.9) in participants with eGFR <60 mL/min/1.73 m(2).

CONCLUSIONS

Contraindicated drug prescription was uncommon but >10% of the population took drugs requiring renal dosing adjustments. Regular monitoring of eGFR may prevent excess mortality associated with inappropriate drug prescription in the elderly.

摘要

背景

肾小球滤过率(GFR)随年龄下降会增加药物剂量不当的风险。我们研究了社区居住的老年人中,根据肾功能选择禁忌或需要剂量调整的药物使用与死亡率之间的相关性。

方法

该研究为三城市人群基础研究,纳入了 1999 年至 2001 年间≥65 岁的 8701 名参与者。风险药物剂量不当的暴露定义为报告使用禁忌药物或需要根据个体基线肾小球滤过率(用肾脏病饮食改良试验方程估算)调整剂量的药物。使用 Cox 模型调整了几个社会人口统计学、生物学和临床危险因素后,分析了 6 年死亡率。

结果

总体风险药物剂量不当的暴露率为 13.3%(禁忌,0.8%):eGFR 为 30-59 的患者中,这一比例为 52.5%(4.5%),eGFR<30 mL/min/1.73 m2 的患者中,这一比例为 96%(48%)。降压药、贝特类和精神类药物是大多数有剂量建议的药物,而抗糖尿病药和抗组胺药是禁忌药物。有风险的患者更可能是男性、年龄较大、正在接受高血压或高胆固醇治疗。在 eGFR<60 mL/min/1.73 m2 的患者中,风险暴露与全因死亡率升高独立相关(危险比 1.4,95%置信区间 1.0-1.9)。

结论

禁忌药物处方不常见,但有>10%的人群使用需要肾脏剂量调整的药物。定期监测肾小球滤过率可能会预防老年人中与药物剂量不当相关的过度死亡率。

相似文献

引用本文的文献

本文引用的文献

4
Renal vulnerability to drug toxicity.肾脏对药物毒性的易感性。
Clin J Am Soc Nephrol. 2009 Jul;4(7):1275-83. doi: 10.2215/CJN.02050309. Epub 2009 Jun 11.
6
CKD as an underrecognized threat to patient safety.慢性肾脏病是对患者安全一种未得到充分认识的威胁。
Am J Kidney Dis. 2009 Apr;53(4):681-8. doi: 10.1053/j.ajkd.2008.12.016. Epub 2009 Feb 26.
8
Timing of onset of CKD-related metabolic complications.慢性肾脏病相关代谢并发症的发病时间。
J Am Soc Nephrol. 2009 Jan;20(1):164-71. doi: 10.1681/ASN.2008020159. Epub 2008 Nov 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验